BASF India Limited
BASF India Limited (BASF) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
basf.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2020 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,507 Cr | 3,326 Cr | 3,360 Cr | 3,967 Cr | 4,248 Cr | 3,759 Cr | 3,287 Cr | 3,875 Cr | 4,045 Cr | 3,863 Cr | 3,444 Cr | 4,824 Cr |
| Operating expenses (approx.) | 2,267 Cr | 3,114 Cr | 3,114 Cr | 3,654 Cr | 4,047 Cr | 3,588 Cr | 3,237 Cr | 3,661 Cr | 3,879 Cr | 3,693 Cr | 3,333 Cr | 4,320 Cr |
| EBITDA | 240 Cr | 212 Cr | 246 Cr | 312 Cr | 201 Cr | 170 Cr | 50 Cr | 214 Cr | 166 Cr | 170 Cr | 111 Cr | 504 Cr |
| OPM % | 9.6% | 6.4% | 7.3% | 7.9% | 4.7% | 4.5% | 1.5% | 5.5% | 4.1% | 4.4% | 3.2% | 10.5% |
| Other income | 6 Cr | 27 Cr | 25 Cr | 22 Cr | 18 Cr | 19 Cr | 20 Cr | 19 Cr | 25 Cr | 11 Cr | 11 Cr | 22 Cr |
| Interest | 6 Cr | 3 Cr | 3 Cr | 5 Cr | 3 Cr | 4 Cr | 4 Cr | 5 Cr | 8 Cr | 5 Cr | 2 Cr | 5 Cr |
| Depreciation | 43 Cr | 49 Cr | 48 Cr | 47 Cr | 45 Cr | 48 Cr | 41 Cr | 41 Cr | 40 Cr | 34 Cr | 37 Cr | 41 Cr |
| Profit before tax | 197 Cr | 187 Cr | 219 Cr | 297 Cr | 171 Cr | 138 Cr | 41 Cr | 188 Cr | 144 Cr | 143 Cr | 90 Cr | 499 Cr |
| Tax % | 41.4% | 25.3% | 26.4% | 25.6% | 25.3% | 24.8% | 33.3% | 26.8% | 25.3% | 25.4% | 23.0% | 26.5% |
| Net profit | 115 Cr | 140 Cr | 161 Cr | 221 Cr | 128 Cr | 104 Cr | 27 Cr | 137 Cr | 107 Cr | 107 Cr | 69 Cr | 360 Cr |
| EPS (₹) | ₹26.60 | ₹32.30 | ₹37.30 | ₹51.00 | ₹29.60 | ₹23.90 | ₹6.20 | ₹31.70 | ₹24.80 | ₹24.60 | ₹16.00 | ₹83.30 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 13,767 Cr | 15,260 Cr | 14,944 Cr | Sign in for TTM |
| Operating expenses (approx.) | 12,878 Cr | 14,527 Cr | 14,284 Cr | Sign in for TTM |
| EBITDA | 890 Cr | 733 Cr | 660 Cr | Sign in for TTM |
| OPM % | 6.5% | 4.8% | 4.4% | Sign in for TTM |
| Other income | 76 Cr | 79 Cr | 66 Cr | Sign in for TTM |
| Interest | 16 Cr | 16 Cr | 19 Cr | Sign in for TTM |
| Depreciation | 191 Cr | 180 Cr | 145 Cr | Sign in for TTM |
| Profit before tax | 759 Cr | 646 Cr | 564 Cr | Sign in for TTM |
| Tax % | 25.8% | 25.8% | 25.7% | Sign in for TTM |
| Net profit | 563 Cr | 479 Cr | 420 Cr | Sign in for TTM |
| EPS (₹) | ₹130.10 | ₹110.70 | ₹97.10 | Sign in for TTM |
| Dividend payout % | 6.1% | 13.5% | 20.6% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 43 Cr | 43 Cr | 43 Cr |
| Reserves | 3,180 Cr | 3,591 Cr | 3,914 Cr |
| Borrowings | — | 32 Cr | — |
| Other liabilities | 4,009 Cr | 4,796 Cr | 4,478 Cr |
| Total liabilities | 7,233 Cr | 8,462 Cr | 8,436 Cr |
| Fixed assets (net) | 758 Cr | 775 Cr | 724 Cr |
| CWIP | 61 Cr | 97 Cr | 160 Cr |
| Investments | 0 Cr | 2 Cr | 8 Cr |
| Loans & advances | 545 Cr | 510 Cr | 0.02 Cr |
| Inventories | 2,116 Cr | 2,922 Cr | 2,709 Cr |
| Trade receivables | 2,522 Cr | 2,594 Cr | 2,734 Cr |
| Cash & bank | 622 Cr | 776 Cr | 869 Cr |
| Other assets | 609 Cr | 786 Cr | 1,231 Cr |
| Total assets | 7,233 Cr | 8,462 Cr | 8,436 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operating activity | 807 Cr | 373 Cr | -110 Cr |
| Cash from investing | -450 Cr | -114 Cr | 379 Cr |
| Cash from financing | -102 Cr | -129 Cr | -179 Cr |
| Net cash flow | 255 Cr | 131 Cr | 89 Cr |
| Free cash flow (OCF − Capex) | 706 Cr | 171 Cr | -316 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | 24.0% | 18.1% | 14.7% |
| ROE % | 17.5% | 13.2% | 0.0% |
| Debtor days | 67 | 62 | 67 |
| Inventory days | 170 | 203 | 218 |
| Days payable | 285 | 292 | 293 |
| Cash conversion cycle | -48 | -27 | -9 |
| Debt / equity | — | 0.0088 | — |
| Current ratio | 1.59 | 1.56 | 1.68 |
| Net debt / EBITDA | -0.70 | -1.01 | -1.32 |
Compare with peers
Loading peers…